Compare Five9 Inc (FIVN) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five9 Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Five9 Inc trades at $36.22 (market cap $2.63B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 2.3× Five9 Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 1,864,393). Which is the better fit depends on your goals — on Pluang, investors hold Five9 Inc for 72 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FIVN | IOVA | |
|---|---|---|
Market Cap | $2.63B | $6.04B |
Volume | 1,864,393 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $38.65 | $14.82 |
52-Week Low | $13.61 | $1.81 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $2.78B | $5.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five9 (FIVN) trades at $36.4, up 7.76% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. Revenue growth is accelerating, reaching $1.15B in 2025, while net income turned positive at $39.42M. The stock is near its 52-week high, supported by strong AI-driven subscription growth and leadership in the contact center-as-a-service market.
Outlook remains positive given robust AI revenue growth and raised guidance, but risks include high valuation multiples and insider selling. Analyst consensus is bullish with a $34 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
